- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2012-000924-16.
Displaying page 1 of 1.
EudraCT Number: 2012-000924-16 | Sponsor Protocol Number: FIL_Veral12 | Start Date*: 2012-11-14 | ||||||||||||||||
Sponsor Name:FONDAZIONE ITALIANA LINFOMI ONLUS | ||||||||||||||||||
Full Title: Phase II randomized study with R-DHAP +/- Bortezomib as induction therapy in relapsed/refractory Diffuse Large B-cell Lymphoma (DLBCL) patients before High-Dose chemotherapy BEAM with autologous st... | ||||||||||||||||||
Medical condition: Younger Patients (18-65 years) with DLBCL who have failed or have relapsed and are eligible to high-dose therapy will be enrolled. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Completed) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
